Product news

Share this article:
Adolor's Entereg (alvimopan) is now available to registered hospitals for helping patients recover gastrointestinal function following bowel resection surgery. Entereg was approved by the FDA on May 20 and is also the first FDA-approved treatment for postoperative ileus, a condition that affects almost all patients undergoing this type of surgery. 
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs


Reimagining healthcare? We want to hear about it.
 
Submit nominations here for MM&M's first-ever list of the Top 40 Healthcare Transformers

Email Newsletters

MM&M inVISION

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.